Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
These findings remain hypothesis-generating with uncertain clinical relevance to rheumatoid arthritis
The 4 mg group lost 17.1%
Exenatide-induced reduction in energy intake is associated with increase in hypothalamic connectivity
Monitoring parameters typically assessed in trials include: Body weight and BMI measured at each visit to track progress Blood glucose and HbA1c particularly important for participants with type 2 diabetes or non-diabetic hyperglycaemia (sometimes called prediabetes) Lipid profile including total cholesterol, LDL, HDL, and triglycerides Liver function tests given the metabolic effects of glucagon receptor activation Renal function especially relevant if gastrointestinal side effects lead to reduced fluid intake Blood pressure and heart rate cardiovascular parameters are routinely assessed Calcitonin levels some trial protocols include calcitonin measurement given the theoretical thyroid C-cell risk associated with GLP-1 receptor agonists, based on rodent data
